T1	Condition 35 52	diabetes mellitus
E1	Condition:T1 Name:T52
T2	And 53 56	and
E2	And:T2 Arg:E1 Arg2:E3
T3	Procedure 57 66	treatment
E3	Procedure:T3 
T4	Condition 73 79	CI-DME
E4	Condition:T4 Name:T54
T5	Assertion 80 89	requiring
E5	Assertion:T5 Asserted:E6
A1	Assertion-Type-Value E5 hypothetical
T6	Procedure 100 107	therapy
E6	Procedure:T6 Name:T55
T8	Procedure 143 152	treatment
E8	Procedure:T8 Provider:E7
T9	Study 201 206	study
E9	Study:T9 
T10	Condition 208 214	CI-DME
E10	Condition:T10 Name:T57
T12	Observation 236 262	central subfield thickness
E12	Observation:T12 Name:T58
T13	Observation 264 267	CST
E13	Observation:T13 Name:T59 Eq-Comparison:E14
T14	Eq-Comparison 269 282	> 300 microns
E14	Eq-Comparison:T14 Operator:T60 Value:T61 Unit:T62
T15	Modifier 286 301	spectral domain
E15	Modifier:T15 Modifies:T63
T16	Procedure 302 330	optical coherence tomography
E16	Procedure:T16 Name:T63
T17	Procedure 332 338	SD-OCT
E17	Procedure:T17 Name:T64
T18	Or 340 342	or
E18	Or:T18 Arg:E13 Arg2:E19
T19	Observation 343 346	CST
E19	Observation:T19 Name:T11 Eq-Comparison:E20
T20	Eq-Comparison 347 360	> 250 microns
E20	Eq-Comparison:T20 Operator:T65 Value:T66 Unit:T67
T21	And 361 365	with
E21	And:T21 Arg:E19 Arg2:E23
T22	Modifier 375 388	intra-retinal
E22	Modifier:T22 Modifies:T68
T23	Condition 389 414	cystic fluid accumulation
E23	Condition:T23 Name:T68
T24	Age 450 453	age
E24	Age:T24 Eq-Comparison:E25
T25	Eq-Comparison 454 464	> 18 years
E25	Eq-Comparison:T25 Operator:T69 Value:T70 Temporal-Unit:T71
T26	Age 529 532	Age
E26	Age:T26 Eq-Comparison:E27
T27	Eq-Comparison 533 543	< 18 years
E27	Eq-Comparison:T27 Operator:T72 Value:T73 Temporal-Unit:T74
T28	Condition 593 627	proliferative diabetic retinopathy
E28	Condition:T28 Name:T75
T29	Other 641 646	other
E29	Other:T29 Is-Other:E30
T30	Condition 655 669	ocular disease
E30	Condition:T30 Name:T77 Severity:T76
T32	Condition 683 703	macular degeneration
E32	Condition:T32 Name:T78
T33	Condition 705 713	glaucoma
E33	Condition:T33 Name:T79
T34	Condition 727 740	media opacity
E34	Condition:T34 Name:T81 Severity:T80
T35	Eq-Comparison 743 762	history of previous
E35	Eq-Comparison:T35 Temporal-Period:T82
T36	Procedure 763 782	intraocular surgery
E36	Procedure:T36 Name:T84 Temporality:E35
T37	Modifier 794 801	macular
E37	Modifier:T37 Modifies:T86
T38	Or 802 804	or
E38	Or:T38 Arg:E37 Arg2:E39
T39	Modifier 805 815	panretinal
E39	Modifier:T39 Modifies:T86
T40	Procedure 816 832	photocoagulation
E40	Procedure:T40 Name:T86
T41	Exception 834 840	except
E41	Exception:T41 From:E40 Except:E45
T43	Or 864 866	or
E43	Or:T43 Arg:E31 Arg2:E44
T44	Modifier 867 883	keratorefractive
E44	Modifier:T44 Modifies:T88
T45	Procedure 884 891	surgery
E45	Procedure:T45 Name:T88 Temporality:E46
T46	Eq-Comparison 892 910	more than 6 months
E46	Eq-Comparison:T46 Operator:T89 Value:T90 Temporal-Unit:T91
T47	Temporal-Connection 911 919	prior to
E47	Temporal-Connection:T47 Arg:E46 Arg2:E48
A3	Temporal-Connection-Type-Value E47 before
T48	Study 920 930	enrollment
E48	Study:T48 
T49	Condition 933 941	pregnant
E49	Condition:T49 Name:T92
T50	Or 942 945	and
E50	Or:T50 Arg:E49 Arg2:E51
T51	Condition 946 953	nursing
E51	Condition:T51 Name:T93
T52	Condition-Name 35 52	diabetes mellitus
T54	Condition-Name 73 79	CI-DME
T55	Procedure-Name 100 107	therapy
T57	Condition-Name 208 214	CI-DME
T58	Observation-Name 236 262	central subfield thickness
A4	Observation-Type-Value T58 measurement
T59	Observation-Name 264 267	CST
T60	Eq-Operator 269 270	>
A5	Eq-Operator-Value T60 GT
T61	Eq-Value 271 274	300
T62	Eq-Unit 275 282	microns
T63	Procedure-Name 302 330	optical coherence tomography
T64	Procedure-Name 332 338	SD-OCT
T65	Eq-Operator 347 348	>
A7	Eq-Operator-Value T65 GT
T66	Eq-Value 349 352	250
T67	Eq-Unit 353 360	microns
T68	Condition-Name 389 414	cystic fluid accumulation
T69	Eq-Operator 454 455	>
A8	Eq-Operator-Value T69 GT
T70	Eq-Value 456 458	18
T71	Eq-Temporal-Unit 459 464	years
A9	Eq-Temporal-Unit-Value T71 year
T72	Eq-Operator 533 534	<
A10	Eq-Operator-Value T72 LT
T73	Eq-Value 535 537	18
T74	Eq-Temporal-Unit 538 543	years
A11	Eq-Temporal-Unit-Value T74 year
T75	Condition-Name 593 627	proliferative diabetic retinopathy
T76	Severity 647 654	serious
A12	Severity-Value T76 severe
T77	Condition-Name 655 669	ocular disease
T78	Condition-Name 683 703	macular degeneration
T79	Condition-Name 705 713	glaucoma
T80	Severity 715 726	significant
A13	Severity-Value T80 severe
T81	Condition-Name 727 740	media opacity
T82	Eq-Temporal-Period 743 762	history of previous
A14	Eq-Temporal-Period-Value T82 past
T84	Procedure-Name 763 782	intraocular surgery
T86	Procedure-Name 816 832	photocoagulation
T88	Procedure-Name 884 891	surgery
T89	Eq-Operator 892 901	more than
A16	Eq-Operator-Value T89 GT
T90	Eq-Value 902 903	6
T91	Eq-Temporal-Unit 904 910	months
A17	Eq-Temporal-Unit-Value T91 month
T92	Condition-Name 933 941	pregnant
T93	Condition-Name 946 953	nursing
T94	Life-Stage-And-Gender 954 959	women
A18	Life-Stage-And-Gender-Type T94 female
T53	Negation 67 72	naÃ¯ve
E52	Negation:T53 Negates:E3
R1	Treatment-For Arg1:E3 Arg2:E1	
T95	Condition 95 99	VEGF
E53	Condition:T95 Name:T96
T96	Condition-Name 95 99	VEGF
R2	Treatment-For Arg1:E6 Arg2:E53	
T7	Provider 112 130	retinal specialist
E7	Provider:T7 Type:T56
T56	Provider-Type 112 130	retinal specialist
R3	Using Arg1:E8 Arg2:E6	
R4	Abbrev-Of Arg1:E13 Arg2:E12	
R5	Equivalent-To Arg1:E12 Arg2:E10	
R6	Found-By Arg1:E13 Arg2:E16	
R7	Abbrev-Of Arg1:E17 Arg2:E16	
T11	Observation-Name 343 346	CST
T31	Modifier 671 682	age-related
E11	Modifier:T31 Modifies:T78
R8	Example-Of Arg1:E32 Arg2:E30	
R9	Example-Of Arg1:E33 Arg2:E30	
R10	Example-Of Arg1:E34 Arg2:E30	
R11	Example-Of Arg1:E40 Arg2:E36	
T42	Modifier 841 863	uncomplicated cataract
E31	Modifier:T42 Modifies:T88
R12	If-Then Arg1:E51 Arg2:T94	
T83	Condition 967 978	sensitivity
E42	Condition:T83 Name:T85
T85	Condition-Name 967 978	sensitivity
T87	Drug 993 1015	supplement ingredients
E54	Drug:T87 
R13	Caused-By Arg1:E42 Arg2:E54	
